SciSparc Ltd. (Nasdaq: SPRC) (the "Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the ...

Using advanced techniques in biophysical chemistry, a team led by Meredith Jackrel, an associate professor of chemistry, has ...

The drug development pipeline is a costly and lengthy process. Identifying high-quality "hit" compounds—those with high ...

The Research Collaboratory for Structural Bioinformatics Protein Data Bank, a global scientific resource based at Rutgers ...

SciSparc (SPRC)announced that on September 16, 2025 the board of directors resolved to initiate the launch of an innovative initiative to advance ...

The use of chromosomes is fundamental to numerous fields, including clinical diagnostics, genetics, and molecular biology ...

Spatial proteomics represents a revolutionary frontier in molecular biology, enabling researchers to explore protein ...

Investing.com -- SciSparc Ltd. (NASDAQ:SPRC) stock rose 2.6% on Thursday after the clinical-stage pharmaceutical company announced plans to launch a new initiative focused on 3D protein modeling using ...

Regulatory agencies, including the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), expect excipients such as surfactants to be appropriately selected, justified, and ...

Electron microscopy of spherical and wormlike Matrin-3 assemblies. (Image: Meredith Jackrel) Using advanced techniques in ...